Clinical Trials

Medical advancements must undergo rigorous testing in the form of clinical trials before they can be made available for general use. Phase I and II studies assess safety. Phase III studies determine if new drugs are effective. Clinical trials represent the final stage of cutting edge science and medicine's pursuit of improved treatments.

NeuroNEXT Trials

The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, conducts Phase II studies of treatment for neurological diseases. The network is sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) and is comprised of 25 national clinical sites. Visit our website at


NeuroNEXT Trials Open to Enrollment

NeuroNEXT Completed Trials

Contact Catherine Canamar, Ph.D.

Neurology Department Clinical Trials

Clinical research activities are ongoing in many subspecialty areas including Alzheimer's disease, epilepsy, multiple sclerosis, amyotrophic lateral sclerosis, neurorehabilitation (stroke and spinal cord injury), and post-polio. For additional clinical trial information, contact the individual program.

Research Contacts and Web Listings of Current Trials by Program

Alzheimer's Disease 310-794-6039
Brain Mapping
Epilepsy 310-825-5745  
Headache 310-794-1870
Infectious Disease

Movement Disorder
  Parkinson's Disease

Multiple Sclerosis 310-206-2176
  Huntington's Disease
  Amyotrophic Lateral Sclerosis

Neuro-Oncology 310-794-3521
  Vestibular Disease

Stroke 310-794-6379

UCLA Principal Investigators may add or update their program's Research Contact, web address, or clinical trial listing on this page. UCLA PIs, click here to email Dr. Canamar your request.

Other Resources about Clinical Trials